Chronic Kidney Disease Improvement in Research and Treatment Act of 2021

The Chronic Kidney Disease Improvement in Research and Treatment Act of 2021 aims to enhance the prevention and treatment of kidney disease for Medicare beneficiaries. If passed, the bill would add kidney disease screenings to annual Medicare wellness visits and expand access to supplemental insurance (Medigap) for patients with end-stage renal disease. Additionally, the legislation seeks to improve patient care by increasing access to kidney disease education and providing financial incentives for healthcare providers to adopt new treatments and technologies.